STERIS plc (STE)
Return on total capital
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | 847,161 | 788,222 | 456,293 | 581,088 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,615,760 | 6,302,160 | 6,087,170 | 6,544,640 | 3,891,470 |
| Return on total capital | 0.00% | 13.44% | 12.95% | 6.97% | 14.93% |
March 31, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $6,615,760K)
= 0.00%
Return on total capital is a key financial ratio that indicates the efficiency and profitability of a company in generating returns from its capital employed. Analyzing the trend in STERIS plc's return on total capital over the past few years, we observe the following progression:
- As of March 31, 2021, STERIS plc's return on total capital stood at 14.93%, reflecting a relatively positive performance in utilizing its total capital to generate profits.
- However, there was a notable decline in the ratio to 6.17% as of March 31, 2022, indicating a decreased efficiency in capital utilization or profitability.
- The company showed improvement in the subsequent years, with the return on total capital increasing to 12.95% as of March 31, 2023, and further to 13.44% as of March 31, 2024, suggesting enhanced effectiveness in utilizing its capital resources.
- Unfortunately, the data for March 31, 2025 is not available, making it challenging to assess the recent performance of STERIS plc in terms of return on total capital.
Overall, the fluctuation in STERIS plc's return on total capital over the analyzed period suggests varying degrees of efficiency in capital utilization and profitability, underscoring the importance of monitoring this ratio to evaluate the company's financial performance.
Peer comparison
Mar 31, 2025